Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Clobazam for Refractory Focal Epilepsy
NCT02726919Phase 4Unknown
- Sponsor
- Mid-Atlantic Epilepsy and Sleep Center
- Start
- Feb 2015
- Primary completion
- Jun 2018
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of clobazam in focal epilepsy, sponsored by Mid-Atlantic Epilepsy and Sleep Center. Status: unknown.
02
Drugs
clobazam
03
Conditions
focal epilepsy
Beyond the preview
Go deeper on NCT02726919.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02726919.